Location: Palo Alto, CA
CIK: 0001892134 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 15, 2024
Total Value: $2.138B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 12,226,943 | $235M | 11.0% | $10.46 | +91.8% | ORDINARY SHARES | N62509109 |
| MIRM | MIRUM PHARMACEUTICALS INC | 6,495,392 | $222M | 10.4% | $23.31 | +12.5% | COM | 604749101 |
| KRYS | KRYSTAL BIOTECH INC | 988,460 | $182M | 8.5% | $64.17 | +161.6% | COM | 501147102 |
| — | HILLEVAX INC | 10,617,062 | $154M | 7.2% | $11.48 | — | COM | 43157M102 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 10,109,279 | $104M | 4.9% | $13.68 | -24.7% | COM | 71722W107 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 2,371,304 | $97.37M | 4.6% | $21.21 | +88.2% | COM | 76243J105 |
| BBIO | BRIDGEBIO PHARMA INC | 3,632,604 | $92.01M | 4.3% | $20.99 | +30.2% | COM | 10806X102 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 8,785,284 | $81.7M | 3.8% | $17.08 | -47.1% | COM | 03969K108 |
| IRON | DISC MEDICINE INC | 1,754,834 | $79.09M | 3.7% | $35.82 | -5.1% | COM | 254604101 |
| PCVX | VAXCYTE INC | 1,039,405 | $78.49M | 3.7% | $21.85 | +211.6% | COM | 92243G108 |
| EWTX | EDGEWISE THERAPEUTICS INC | 3,731,067 | $67.2M | 3.1% | $10.16 | +71.7% | COM | 28036F105 |
| ANAB | ANAPTYSBIO INC | 2,165,591 | $54.27M | 2.5% | $26.18 | -11.1% | COM | 032724106 |
| — | VERONA PHARMA PLC | 3,314,349 | $47.93M | 2.2% | $14.55 | — | SPONSORED ADS | 925050106 |
| KALV | KALVISTA PHARMACEUTICALS INC | 3,687,867 | $43.44M | 2.0% | $9.73 | +20.0% | COM | 483497103 |
| TARS | TARSUS PHARMACEUTICALS INC | 1,587,527 | $43.15M | 2.0% | $17.82 | +88.7% | COM | 87650L103 |
| RVMD | REVOLUTION MEDICINES INC | 997,455 | $38.71M | 1.8% | $25.35 | +47.5% | COM | 76155X100 |
| ERAS | ERASCA INC | 16,216,216 | $38.27M | 1.8% | $2.16 | 0.0% | COM | 29479A108 |
| AGIO | AGIOS PHARMACEUTICALS INC | 871,974 | $37.6M | 1.8% | $29.24 | +23.4% | COM | 00847X104 |
| SLNO | SOLENO THERAPEUTICS INC | 875,667 | $35.73M | 1.7% | $24.43 | +73.5% | COM | 834203309 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,561,230 | $33.61M | 1.6% | $18.73 | +22.6% | COM | 77313F106 |
| SVRA | SAVARA INC | 8,157,385 | $32.87M | 1.5% | $4.02 | +10.8% | COM | 805111101 |
| ORIC | ORIC PHARMACEUTICALS INC | 4,142,855 | $29.29M | 1.4% | $8.67 | +3.2% | COM | 68622P109 |
| CGON | CG ONCOLOGY INC | 770,000 | $24.31M | 1.1% | $40.84 | -15.1% | COM | 156944100 |
| PEPG | PEPGEN INC | 1,502,788 | $23.98M | 1.1% | $11.81 | +21.4% | COM | 713317105 |
| — | MERUS N V | 373,100 | $22.08M | 1.0% | $25.59 | — | COM | N5749R100 |
| TRVI | TREVI THERAPEUTICS INC | 7,381,090 | $22M | 1.0% | $2.78 | -0.2% | COM | 89532M101 |
| SLN | SILENCE THERAPEUTICS PLC | 1,148,591 | $21.82M | 1.0% | $19.61 | — | ADS | 82686Q101 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 425,000 | $17.47M | 0.8% | $42.70 | 0.0% | COM | 90400D108 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 4,623,324 | $16.09M | 0.8% | $4.59 | — | SPON ADS | 05280R100 |
| — | CEREVEL THERAPEUTICS HLDNG I | 393,000 | $16.07M | 0.8% | $28.54 | — | COM | 15678U128 |
| MREO | MEREO BIOPHARMA GROUP PLC | 4,401,371 | $15.84M | 0.7% | $3.60 | — | SPON ADS | 589492107 |
| IMTX | IMMATICS N.V | 1,152,456 | $13.39M | 0.6% | $11.27 | 0.0% | SHS | N44445109 |
| TYRA | TYRA BIOSCIENCES INC | 832,220 | $13.31M | 0.6% | $11.75 | +46.5% | COM | 90240B106 |
| MGNX | MACROGENICS INC | 3,010,727 | $12.8M | 0.6% | $7.08 | +37.5% | COM | 556099109 |
| — | APPLIED THERAPEUTICS INC | 2,286,135 | $10.68M | 0.5% | $6.49 | — | COM | 03828A101 |
| PBYI | PUMA BIOTECHNOLOGY INC | 3,062,558 | $9.984M | 0.5% | $5.30 | -17.2% | COM | 74587V107 |
| — | 89BIO INC | 1,000,000 | $8.01M | 0.4% | $11.17 | — | COM | 282559103 |
| — | ELEVATION ONCOLOGY INC | 2,958,579 | $7.988M | 0.4% | $2.70 | — | COM | 28623U101 |
| COGT | COGENT BIOSCIENCES INC | 936,576 | $7.895M | 0.4% | $7.30 | +3.8% | COM | 19240Q201 |
| ACAD | ACADIA PHARMACEUTICALS INC | 470,338 | $7.643M | 0.4% | $17.25 | -6.4% | COM | 004225108 |
| ARVN | ARVINAS INC | 285,331 | $7.596M | 0.4% | $67.21 | -52.6% | COM | 04335A105 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,069,244 | $7.335M | 0.3% | $6.86 | — | COM NEW | 00773U207 |
| ALLO | ALLOGENE THERAPEUTICS INC | 2,867,750 | $6.682M | 0.3% | $4.17 | -29.3% | COM | 019770106 |
| ANTX | AN2 THERAPEUTICS INC | 2,088,889 | $4.491M | 0.2% | $8.33 | -71.4% | COM | 037326105 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 500,333 | $4.363M | 0.2% | $0.87 | — | *W EXP 11/22/202 | N62509117 |
| DSGN | DESIGN THERAPEUTICS INC | 1,195,179 | $4.004M | 0.2% | $3.90 | 0.0% | COM | 25056L103 |
| IMCR | IMMUNOCORE HLDGS PLC | 108,762 | $3.686M | 0.2% | $33.89 | — | ADS | 45258D105 |
| MGX | METAGENOMI INC | 245,692 | $1.002M | 0.0% | $11.50 | -40.2% | COM | 59102M104 |
| ACRS | ACLARIS THERAPEUTICS INC | 264,377 | $291K | 0.0% | $13.64 | -91.4% | COM | 00461U105 |